Possible effect of epinephrine in minimizing COVID-19 severity: a review

2019 Novel coronavirus: where we are and what we know

(2020) Zhangkai J. Cheng et al.   INFECTION

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

(2020) Zunyou Wu et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19

(2020) Irani Thevarajan et al.   NATURE MEDICINE

Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020

(2020) et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19

(2020) Krishan D. Chhiba et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Estimates of the severity of coronavirus disease 2019: a model-based analysis

(2020) Robert Verity et al.   LANCET INFECTIOUS DISEASES

An overview of the role of sympathetic regulation of immune responses in infectious disease and autoimmunity

(2018) Mark J. Bucsek et al.   INTERNATIONAL JOURNAL OF HYPERTHERMIA

Cortisol and epinephrine control opposing circadian rhythms in T cell subsets

(2009) S. Dimitrov et al.   BLOOD